[Senate Hearing 114-846]
[From the U.S. Government Publishing Office]





                                                        S. Hrg. 114-846
 
                                [ERRATA]
                   VALEANT PHARMACEUTICALS' BUSINESS
                      MODEL: THE REPERCUSSIONS FOR
                        PATIENTS AND THE HEALTH
                              CARE SYSTEM

=======================================================================

                                HEARING

                               BEFORE THE

                       SPECIAL COMMITTEE ON AGING

                          UNITED STATES SENATE

                    ONE HUNDRED FOURTEENTH CONGRESS


                             SECOND SESSION

                               __________

                             WASHINGTON, DC

                               __________

                             APRIL 27, 2016

                               __________

                           Serial No. 114-24

         Printed for the use of the Special Committee on Aging


        Available via the World Wide Web: http://www.govinfo.gov


      
      
                              ______                       


             U.S. GOVERNMENT PUBLISHING OFFICE 
 48-176 PDF           WASHINGTON : 2022       
      
      

                                [ERRATA]

    An error was made in the hearing Valeant Pharmaceuticals' 
Business Model: the Repercussions for Patients and the Health 
Care System. The name Priscilla Hanley was inadvertently listed 
in the Committee member section instead of Mark B. LeDuc as the 
Majority Staff Director for the Special Committee on Aging.